Evidence map›Paper›PMID 25200434›Full record

ArticleMolecular biology reports2014

Genetic transformation of date palm (Phoenix dactylifera L. cv. 'Estamaran') via particle bombardment.

Mousa Mousavi, Amir Mousavi, Ali Akbar Habashi, Bahareh Dehsara

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Genetic Transformation System for Woody PlantFrontiers in plant science · 2017
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mousa MousaviNational Institute of Genetic Engineering and Biotechnology, P.O. Box 14155-6343, Tehran, Iran, mousa_mousawi@yahoo.com.
Amir Mousavi
Ali Akbar Habashi
Bahareh Dehsara

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, an efficient transformation system for gene delivery in date palm was established. The effects of different physical and biological parameters were optimized for transient transformation of uidA gene in somatic embryos of Estamaran cultivar. The tissues were bombarded with constructs harboring the uidA gene driven by CaMV 35S or rice Act1 promoter. Efficiency of expression was estimated by comparison of the number of blue spots resulted from GUS assay. Optimal transient expression was observed when explants were precultured on a media containing 0.4 M mannitol with air desiccation and bombarded at acceleration pressure of 1,350 psi, target distance of 6 cm with gold particles size of 0.6 µm which coated with 2.5 µg of DNA and at chamber vacuum pressure of 28 inHg. Significantly higher expression levels were obtained in tissues when the construct having the Act1 promoter was employed. After bombardment, somatic embryos were transferred to the regeneration media containing MS basal salts supplements with 3 mg/l 2ip, 40 mg/l adenine, 1 mg/l 2,4-D, 30 g/l sucrose and 3 g/l activated charcoal. Regenerated plantlets were checked by PCR using gene-specific primers. About 16 % of the plantlets were reported to be stably transformed. Southern analysis of genomic DNA from transformed plants showed that 1-2 gene (uidA) copies were integrated and GUS-negative plants did not contain any transgene. Achievement of these data considered as the first report of its kind is believed to facilitate transfer of desirable traits in date palm.

Indexed as

Transformation, GeneticBiolisticsCulture MediaGoldMannitolParticle SizePhoeniceaePlant ProteinsPlants, Genetically ModifiedRecombinant ProteinsCulture MediaGoldMannitolPlant ProteinsRecombinant Proteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.